InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,716.80
(
0.19%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.25
(
0.04%
)
Bitcoin
62,978.06
(
0.12%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: Shiskabill post# 89172

Thursday, 10/01/2015 8:17:59 AM

Thursday, October 01, 2015 8:17:59 AM

Post# of 92948
Shiskabill $OCAT official 60 persons, 3 cohort AMD trial

https://clinicaltrials.gov/ct2/show/NCT02563782?term=MA09-hRPE&rank=8


Sham Comparator: Control group
Sham surgery and placebo immunosuppressive therapy (IMT)
Drug: Placebo tacrolimus and mycophenolate mofetil Procedure: Sham Surgery

Active Comparator: Active Group
Sub-retinal transplantation of MA09-hRPE cells and IMT
Biological: Sub-retinal transplantation of MA09-hRPE cells Drug: tacrolimus and mycophenolate mofetil Immunosuppressive Agents



The amount of RPEs will be 200K.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up